SAN FRANCISCO--(BUSINESS WIRE)--Obagi Medical Products, Inc. (Nasdaq:OMPI), a leader in topical aesthetic and therapeutic skin health systems, announced today results from a new clinical study that showed that its Condition & Enhance System, when combined with Intense Pulsed Light (IPL) treatments, provided greater improvement in overall facial appearance as well as increased patient satisfaction vs. IPL treatments with placebo.
